MedTrace Logo

Multi-center Trial of SPECT Myocardial Blood Flow Quantitation for Detection of Coronary Artery Disease

NCT03637725 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 221

Last updated 2022-02-02

No results posted yet for this study

Summary

Patients with suspected or known coronary artery disease who are scheduled for clinically indicated SPECT myocardial perfusion imaging (MPI) and will receive invasive coronary angiogram are recruited to receive SPECT MBF study.

Conditions

Sponsors & Collaborators

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Principal Investigators

  • Wei Fang, MD/PhD · Fu Wai Hospital, Beijing, Chia

  • Jianming Li, MD/PhD · TEDA International Cardiovascular Hospital

  • Yuming Zheng, MD · China-Japanese Friendship Hospital, Beijing, China

  • Jie Zhang, MD/MS · Central China Fuwai Hospital, Henan, China

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-03
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03637725 on ClinicalTrials.gov